[go: up one dir, main page]

AR004178A1 - PROCEDURE FOR THE FORMULATION OF A PHARMACY, A PHARMACEUTICAL COMPOSITION OBTAINABLE THROUGH THIS PROCEDURE AND THE USE OF THE SAME. - Google Patents

PROCEDURE FOR THE FORMULATION OF A PHARMACY, A PHARMACEUTICAL COMPOSITION OBTAINABLE THROUGH THIS PROCEDURE AND THE USE OF THE SAME.

Info

Publication number
AR004178A1
AR004178A1 ARP960103748A AR10374896A AR004178A1 AR 004178 A1 AR004178 A1 AR 004178A1 AR P960103748 A ARP960103748 A AR P960103748A AR 10374896 A AR10374896 A AR 10374896A AR 004178 A1 AR004178 A1 AR 004178A1
Authority
AR
Argentina
Prior art keywords
procedure
formulation
pharmacy
pharmaceutical composition
same
Prior art date
Application number
ARP960103748A
Other languages
Spanish (es)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR004178A1 publication Critical patent/AR004178A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un procedimiento para formulación de fármacos, que comprende mezclar partículas de un vehículo con una solución de un fármaco monohidrocloruro de[R-(Z)]-alfa-(metoximiimino)-alfa-(1-azabiciclo[2.2.2]-oct-3-il)acetonitrilo, en agua en unacan tidad de 1-3% en peso de solución a mezcla total,composiciones farmacéuticas utilizadas en él y el uso de dichas composiciones farmacéuticas en el tratamiento y/o profilaxis de la demencia.A method for drug formulation, which comprises mixing particles of a carrier with a solution of a [R- (Z)] - alpha- (methoxyimino) -alpha- (1-azabicyclo [2.2.2] -oct- 3-yl) acetonitrile, in water in an amount of 1-3% by weight of solution to total mixture, pharmaceutical compositions used therein and the use of said pharmaceutical compositions in the treatment and / or prophylaxis of dementia.

ARP960103748A 1995-07-29 1996-07-25 PROCEDURE FOR THE FORMULATION OF A PHARMACY, A PHARMACEUTICAL COMPOSITION OBTAINABLE THROUGH THIS PROCEDURE AND THE USE OF THE SAME. AR004178A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process

Publications (1)

Publication Number Publication Date
AR004178A1 true AR004178A1 (en) 1998-11-04

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103748A AR004178A1 (en) 1995-07-29 1996-07-25 PROCEDURE FOR THE FORMULATION OF A PHARMACY, A PHARMACEUTICAL COMPOSITION OBTAINABLE THROUGH THIS PROCEDURE AND THE USE OF THE SAME.

Country Status (25)

Country Link
EP (1) EP0841902A2 (en)
JP (1) JPH11510493A (en)
KR (1) KR19990035972A (en)
CN (1) CN1196677A (en)
AP (1) AP858A (en)
AR (1) AR004178A1 (en)
AU (1) AU716961B2 (en)
BG (1) BG102266A (en)
BR (1) BR9609804A (en)
CA (1) CA2228048A1 (en)
CZ (1) CZ24798A3 (en)
DZ (1) DZ2077A1 (en)
EA (2) EA199901055A1 (en)
HU (1) HUP9900521A3 (en)
IL (1) IL122897A0 (en)
MA (1) MA23953A1 (en)
MX (1) MX9800809A (en)
NO (1) NO980384L (en)
NZ (1) NZ315632A (en)
OA (1) OA10659A (en)
PL (1) PL325242A1 (en)
SK (1) SK11098A3 (en)
TR (1) TR199800156T1 (en)
UY (1) UY24297A1 (en)
WO (1) WO1997004750A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
IL138192A0 (en) * 1998-03-11 2001-11-25 Smithkline Beecham Plc Controlled release oral dosage forms
FR2796840B1 (en) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques LOW-DOSE TABLETS AND METHOD OF PREPARATION
PT1591121E (en) 2000-12-14 2009-07-20 Ortho Mcneil Janssen Pharm Process for preparing steroid hormone products comprising a stabilizing agent in non-crystalline form
US20070202179A1 (en) * 2004-04-09 2007-08-30 FAULKNER Patrick Low Dose Pharmaceutical Products
WO2026018154A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with non-cns penetrant muscarinic antagonists
WO2026018155A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with long-acting non-cns penetrant muscarinic antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (en) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd Wet solid pharmaceutical preparation of very small amount of main drug
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
EP0392803B1 (en) * 1989-04-13 2004-06-16 Beecham Group p.l.c. Novel compounds
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
AU6738496A (en) 1997-02-26
MA23953A1 (en) 1997-04-01
CA2228048A1 (en) 1997-02-13
EA199901055A1 (en) 2000-06-26
IL122897A0 (en) 1998-08-16
UY24297A1 (en) 1997-01-23
TR199800156T1 (en) 1998-04-21
EA000740B1 (en) 2000-02-28
EA199800179A1 (en) 1998-10-29
WO1997004750A3 (en) 1997-03-27
CZ24798A3 (en) 1998-06-17
BG102266A (en) 1998-10-30
MX9800809A (en) 1998-04-30
HUP9900521A3 (en) 2001-04-28
SK11098A3 (en) 1998-07-08
OA10659A (en) 2002-09-18
NZ315632A (en) 1999-11-29
CN1196677A (en) 1998-10-21
NO980384D0 (en) 1998-01-28
AU716961B2 (en) 2000-03-09
WO1997004750A2 (en) 1997-02-13
AP9801170A0 (en) 1998-01-31
JPH11510493A (en) 1999-09-14
KR19990035972A (en) 1999-05-25
DZ2077A1 (en) 2002-07-22
PL325242A1 (en) 1998-07-06
HUP9900521A2 (en) 1999-06-28
EP0841902A2 (en) 1998-05-20
AP858A (en) 2000-07-12
BR9609804A (en) 1999-07-06
NO980384L (en) 1998-03-26

Similar Documents

Publication Publication Date Title
PT101061A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANAGOLS OF CAMPTOTECIN AND A PLATINUM COORDINATION COMPOUND AND ITS USE IN THE INHIBITION OF TUMOR CELL GROWTH
ES2149276T3 (en) IMIDAZO (4,5-C) PIRIDIN-4-AMINAS.
AR003455A1 (en) TETRACICLIC DERIVATIVES, THEIR USE IN THE PREPARATION OF A MEDICINAL PRODUCT, A TREATMENT METHOD, A PHARMACEUTICAL COMPOSITION AND PROCESSES FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION AND TO PREPARE THE COMPOUNDS.
HUT68251A (en) Antiviral 2-ethyl-1h-imidazo(4,5-c)quinolin-4-amines and pharmaceutical compositions containing them
MX9700223A (en) Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension.
MX9300603A (en) THIACICLIC DERIVATIVES OF PIPERIDINYL.
IL91361A0 (en) Tricyclic compounds,processes for the preparation thereof and pharmaceutical compositions containing the same
IL117824A (en) Pharmaceutical compositions containing 2-aryl-imidazol¬1,2-a¾pyridine-3-acetamide derivatives for treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia
ITMO920035A1 (en) DROPPER BOTTLE PARTICULARLY FOR PHARMACEUTICAL PRODUCTS ACTIVATED FOR MIXING USE
HUP0103203A2 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
ES2076595T3 (en) DERIVATIVES OF AMIDINOPHENYLALANINE, PROCEDURE FOR ITS PREPARATION, ITS EMPLOYMENT AND AGENTS THAT CONTAIN THEM.
ES2111163T3 (en) USE OF PHOSPHONATES FOR THE TREATMENT OF OSTEOPOROSIS.
AR004178A1 (en) PROCEDURE FOR THE FORMULATION OF A PHARMACY, A PHARMACEUTICAL COMPOSITION OBTAINABLE THROUGH THIS PROCEDURE AND THE USE OF THE SAME.
MX9401080A (en) HETEROAROMATIC COMPOUNDS.
MX9704034A (en) DERIVATIVES AND COMPOSITIONS OF SUBSTITUTED 2-ARYLCARBONYLOXYMETHYL-1,2,5-TIADIAZOLIDIN-3-ONA 1,1-DIOXIDE AND METHOD OF USE.
FI944933A7 (en) 7-Disubstituted methyl-4-oxo-3H,5H-pyrrolo(3,2-d) pyrimidine and pharmaceutical uses and compositions containing the same
MX9307203A (en) STEROIDAL COMPOUNDS OF ACIL-3-CARBOXI-3,5-DIENO-17Ó AND 17ß-SUBSTITUTED.
ES2086528T3 (en) NEW BICYCLE COMPOUNDS REPLACED WITH AMINO.
PA8496701A1 (en) POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO [2.2.2] OCT- 3 - ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS
IL67925A0 (en) Laevorotatory isomer of mequitazine,its preparation and pharmaceutical compositions containing it
IL105349A0 (en) Pharmaceutical compositions containing beta-carbolines,methods for the preparation thereof and compounds for use in the preparation thereof
FI822671L (en) AMINOGLYCOSIDE DERIVATIVES, PHARMACEUTICAL COMPOSITION FOR FRAMSTAELLNING AV DEM, PHARMACEUTICAL COMPOSITION INNEHAOLLANDE DEM
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
MX9302578A (en) ANTIVIRAL AGENTS.
AR026756A1 (en) NEW THERAPEUTIC COMBINATIONS (S) -2-BENCILAMINO-METIL) -2,3,8,9-TETRAHIDRO-7H-1,4-DIOXINO [2,3-E] INDOL-8-ONA AND NEUROLETICS FOR THE OPREVENTION TREATMENT OF PSYCHOTIC DISORDERS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal